Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...
A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results